David W. Wray, PhD
VA Salt Lake City Health Care System, Salt Lake City, UT
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name David W. Wray, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:12 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT06312748 · Novel Approaches for Improving Vascular Function in Veterans With HFpEFVA Office of Research and Development · recruiting · Heart Failure With Preserved Ejection Fraction, Inflammation · principal investigator
- N/ANCT05648630 · Improving Exercise Rehabilitation Efficacy Outcomes Veterans Peripheral Artery DiseaseVA Office of Research and Development · withdrawn · Peripheral Artery Disease (D058729), Oxidative Stress (D018384), Inflammation (D007249) · principal investigator
- Early Ph1NCT03136029 · Exercise and NO in HFrEFVA Office of Research and Development · completed · Heart Failure With Reduced Ejection Fraction · principal investigator
- Early Ph1NCT02124824 · Contribution of Endothelin-1 to Exercise Intolerance in Heart FailureVA Office of Research and Development · completed · Heart Failure · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:12 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.